Sub-site | Number of patients | Doubling time | Flow Cytometric (FCM) | Immunohistochemical (Hi) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
days | Dp(0.25) | Dp(0.3) | Dp(0.35) | days | Dp(0.25) | Dp(0.3) | Dp (0.35) | |||
Oral Cavity | 394 (18.2%) | T D | 6.6 (5.5-8.2) | 0.35 (0.28-0.42) | 0.29 (0.23-0.35) | 0.25 (0.20-0.30) | 5.9 (4.9-7.4) | 0.39 (0.31-0.47) | 0.33 (0.26-0.39) | 0.28 (0.22-0.34) |
T pot | 3.9 | 0.59 | 0.49 | 0.42 | 2.3 | 1.00 | 0.84 | 0.72 | ||
Oropharynx | 655 (30.3%) | T D | 6.6 (5.5-8.2) | 0.35 (0.28-0.42) | 0.29 (0.23-0.35) | 0.25 (0.20-0.30) | 5.9 (4.9-7.4) | 0.39 (0.31-0.47) | 0.33 (0.26-0.39) | 0.28 (0.22-0.34) |
T pot | 3.9 | 0.59 | 0.49 | 0.42 | 2.3 | 1.00 | 0.84 | 0.72 | ||
Hypopharynx | 320 (14.8%) | T D | 6.1 (5.1-7.6) | 0.38 (0.30-0.45) | 0.31 (0.25-0.38) | 0.27 (0.22-0.32) | 4.6 (3.9-5.8) | 0.50 (0.40-0.59) | 0.42 (0.33-0.49) | 0.36 (0.28-0.42) |
T pot | 3.6 | 0.64 | 0.53 | 0.46 | 1.8 | 1.28 | 1.07 | 0.92 | ||
Larynx | 784 (36.3%) | T D | 12.9 (10.7-16.0) | 0.18 (0.14-0.22) | 0.15 (0.12-0.18) | 0.13 (0.10-0.15) | 14.3 (12.4-18.1) | 0.16 (0.13-0.19) | 0.14 (0.11-0.16) | 0.12 (0.9-0.13) |
T pot | 7.6 | 0.30 | 0.25 | 0.46 | 5.6 | 0.41 | 0.34 | 0.29 |